Epithelial ovarian cancer.
作者： Joseph S. Ng , Jeffrey J.H. Low , A. Ilancheran
DOI: 10.1016/J.BPOBGYN.2011.12.005
关键词:
摘要: The incidence of epithelial ovarian cancer in women aged 40 years and younger is 3–17%. management these challenging requires balancing the need to treat adequately preserving reproductive potential. Fertility-sparing surgery, especially for early stage cancer, seems be associated with equivalent clinical outcomes while A complete staging cytoreductive procedure retaining uterus, at least one grossly normal ovary, minimum recommended procedure. Adjuvant chemotherapy a platinum-taxane combination as clinically indicated, better survival outcomes. treatment does not seem increase risk congenital anomalies subsequent pregnancies. Targeted therapy cryopreservation are largely experimental cannot part standard care.
bestpracticeobgyn.com
elsevier.com参考文章(43)
H. L. Kottmeier, Surgical Management — Conservative Surgery Ovarian Cancer. pp. 157- 164 ,(1968) , 10.1007/978-3-642-87755-1_12
Spinelli J, Yang N, Swenerton Kd, Hislop Tg, Boyes Da, LeRiche Jc, Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstetrics & Gynecology. ,vol. 65, pp. 264- ,(1985)
John O. Schorge, Leslie A. Garrett, Annekathryn Goodman, Cytoreductive surgery for advanced ovarian cancer: quo vadis? Oncology. ,vol. 25, pp. 928- ,(2011)
A.P.M. Heintz, F. Odicino, P. Maisonneuve, U. Beller, J.L. Benedet, W.T. Creasman, H.Y.S. Ngan, S. Pecorelli, Carcinoma of the ovary. Journal of Epidemiology and Biostatistics. ,vol. 6, pp. 107- 138 ,(2001) , 10.1016/S0020-7292(03)90118-4
W P McGuire, W J Hoskins, M F Brady, H D Homesley, W T Creasman, M L Berman, H Ball, J S Berek, J Woodward, Assessment of Dose-Intensive Therapy in Suboptimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study Journal of Clinical Oncology. ,vol. 13, pp. 1589- 1599 ,(1995) , 10.1200/JCO.1995.13.7.1589
Equinn W. Munnell, Is conservative therapy ever justified in Stage I (IA) cancer of the ovary American Journal of Obstetrics and Gynecology. ,vol. 103, pp. 641- 653 ,(1969) , 10.1016/0002-9378(69)90561-4
Ahmed Elattar, Andrew Bryant, Brett A Winter-Roach, Mohamed Hatem, Raj Naik, Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database of Systematic Reviews. ,vol. 2011, ,(2011) , 10.1002/14651858.CD007565.PUB2
Philippe Morice, Fabienne Wicart-Poque, Annie Rey, Janah El-Hassan, Patricia Pautier, Catherine Lhomm�, Renaud de Crevoisier, Christine Haie-Meder, Pierre Duvillard, Damienne Castaigne, Results of conservative treatment in epithelial ovarian carcinoma. Cancer. ,vol. 92, pp. 2412- 2418 ,(2001) , 10.1002/1097-0142(20011101)92:9<2412::AID-CNCR1590>3.0.CO;2-7
Naifu Liu, Xingwu Wang, Xiugui Sheng, None, 'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis. Current Opinion in Obstetrics & Gynecology. ,vol. 23, pp. 19- 23 ,(2011) , 10.1097/GCO.0B013E32834252F5
Tate Thigpen, Mark F. Brady, George A. Omura, William T. Creasman, William P. Mcguire, William J. Hoskins, Stephen Williams, Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience Cancer. ,vol. 71, pp. 606- 614 ,(2010) , 10.1002/CNCR.2820710218